SCARLETT FORD: Open Payments
NPI 1124362215 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,398 in 147 payments from 19 companies in 2025. Trend: 2023 $1,711 · 2024 $2,944 · 2025 $3,398
Food & beverage: $3,398
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 12 | $347 |
| Novo Nordisk Inc | 16 | $325 |
| Sequel Med Tech, LLC | 9 | $287 |
| Abbott Laboratories | 11 | $286 |
| Mannkind Corporation | 12 | $281 |
| Lilly USA, LLC | 14 | $274 |
| CeQur Corporation | 1 | $254 |
| Xeris Pharmaceuticals, Inc. | 11 | $239 |
| Insulet Corporation | 8 | $201 |
| Tandem Diabetes Care, Inc. | 7 | $186 |
Products named: MINIMED 780G, Ozempic, TWIIST, FREESTYLE LIBRE 3, AFREZZA, CeQur Simplicity, GVOKE HYPOPEN, MOUNJARO.
Industry payments across TN — which companies pay providers there.
